Keyshla Pagan Morales
Cardiovascular Disease · Southfield, MINPI 1033792791
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.9% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for cardiovascular disease clinicians in MI, where the typical reported total is $2,775.
Across 73 payments — averaging $44.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$438
- Kestra Medical Technology Services, Inc.$419
- Chiesi USA, Inc.$369
- Amgen$355
- Medtronic$301
- Edwards Lifesciences$261
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,07595%
- Education$1645%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 10 | $438 |
| Kestra Medical Technology Services, Inc. | 8 | $419 |
| Chiesi USA, Inc. | 11 | $369 |
| Amgen | 3 | $355 |
| Medtronic | 4 | $301 |
| Edwards Lifesciences | 2 | $261 |
| Abiomed | 6 | $255 |
| Stryker | 3 | $191 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $127 |
| AstraZeneca | 7 | $125 |
| Novartis | 4 | $76 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $75 |
| Pfizer | 3 | $74 |
| Boston Scientific | 1 | $38 |
| Boehringer Ingelheim | 1 | $34 |
| Merck | 1 | $24 |
| Bayer | 1 | $23 |
| Bridgebio Pharma, Inc. | 1 | $18 |
| Teleflex LLC | 1 | $18 |
| Inari Medical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$355
- Assure WCD$270
- SAPIEN 3 Ultra RESILIA$244
- ARTIX MT$150
- CARDIOMEMS$148
- ENSITE$144
- COREVALVE EVOLUT R$122
- KENGREAL$102
How this compares
$3,240 in reported general payments places this provider in the 50th percentile of 760 cardiovascular disease providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 12 | $88 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Southfield
- Herman KadoSouthfield$442K
- Marschall RungeAnn Arbor$1.8M
- Jihad MustaphaGrand Rapids$1.6M
- Vallerie McLaughlinAnn Arbor$947K
- Pedro Villablanca SpinettoDetroit$620K
- Stanley ChetcutiAnn Arbor$573K
- David HainesRoyal Oak$492K
- Steven AlmanyTroy$471K
- David StroblLansing$445K
- Douglas HorstmanshofRoyal Oak$407K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.